Growth & profitability
- Revenue has grown 15.9% per year over the past 5 years.
- Operating margin has contracted, at -70.1% in the latest year.
Financial health
- Total debt has grown slower than revenue (0.6% vs 15.9% per year).
6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $56M | $19M | 50.6% | -70.1% | -$25M | — | $71M |
| 2024 | $48M | -$72M | 51.3% | -120.2% | -$31M | — | $44M |
| 2023 | $50M | -$36M | 50.4% | -85.1% | -$27M | — | $121M |
| 2022 | $47M | -$34M | 55.5% | -75.5% | -$23M | $15M | $188M |
| 2021 | $42M | -$22M | 55.0% | -52.3% | -$30M | $15M | $224M |
| 2020 | $27M | -$13M | 55.5% | -21.6% | $4M | $15M | $159M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $13M | -$12M | 51.4% | -96.3% | $1M | — | $68M |
| Dec '25 | $17M | $4M | 52.7% | 17.8% | $1M | — | $71M |
| Sep '25 | $14M | -$15M | 52.5% | -116.6% | -$5M | — | $63M |
| Jun '25 | $13M | -$13M | 48.9% | -116.3% | -$6M | — | $62M |
| Mar '25 | $12M | $44M | 47.0% | -93.6% | -$15M | — | $79M |
| Dec '24 | $14M | -$19M | 46.5% | -116.8% | -$2M | — | $44M |
| Sep '24 | $15M | -$29M | 53.6% | -168.7% | -$6M | — | $45M |
| Jun '24 | $11M | -$13M | 53.8% | -74.5% | -$12M | — | $47M |
| Mar '24 | $7M | -$11M | 52.4% | -102.5% | -$10M | — | $105M |
| Dec '23 | $14M | -$7M | 50.7% | -67.7% | -$2M | — | $121M |
| Sep '23 | $14M | -$7M | 55.0% | -63.6% | -$5M | — | $118M |
| Jun '23 | $12M | -$9M | 47.9% | -90.4% | -$8M | — | $133M |
| Mar '23 | $9M | -$13M | 46.2% | -137.2% | -$12M | — | $161M |
| Dec '22 | $12M | -$10M | 50.9% | -88.8% | -$6M | $15M | $188M |
| Sep '22 | $16M | -$6M | 59.1% | -45.3% | -$6M | $15M | $194M |
| Jun '22 | $11M | -$8M | 59.7% | -75.4% | -$10M | $15M | $213M |
| Mar '22 | $8M | -$9M | 49.7% | -114.6% | -$1M | $15M | $223M |
| Dec '21 | $16M | -$3M | 57.7% | -22.3% | -$9M | $15M | $224M |
| Sep '21 | $13M | -$5M | 54.3% | -42.1% | -$3M | $15M | $139M |
| Jun '21 | $8M | -$7M | 52.9% | -90.1% | -$8M | $15M | $141M |
How the market has priced MASS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, 908 Devices Inc.'s revenue has grown 15.9% per year. These are computed facts, not advice.
As of FY2025, 908 Devices Inc. reported — of total debt against $71M of cash.
In FY2025, gross margin was 50.6%, operating margin -70.1%, and net margin 34.7%.
As of Jun '26, 908 Devices Inc. traded at a price-to-earnings ratio of about 17.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.